Clinical biomarkers in sepsis

Area of Science:

• Critical Care Medicine
• Biomarker Discovery
• Infectious Diseases

Background:

• Sepsis is a leading cause of mortality in intensive care units.
• Current diagnostic criteria for sepsis are often nonspecific, leading to delayed diagnosis and treatment.
• Timely resuscitation, perfusion restoration, and antibiotic therapy are crucial for reducing sepsis mortality.

Purpose of the Study:

• To review and summarize the most important clinical biomarkers for sepsis.
• To discuss the clinical relevance and application of these biomarkers in diagnosis, therapy monitoring, and outcome prediction.

Main Methods:

• Literature review of recently proposed and established sepsis biomarkers.
• Analysis of the clinical utility and evidence supporting various diagnostic and prognostic markers.
• Synthesis of current knowledge on the role of biomarkers in sepsis management.

Main Results:

• Several molecules have been investigated as sepsis biomarkers, with some transitioning to clinical practice.
• Biomarkers are increasingly valuable for accelerating sepsis diagnosis.
• Established biomarkers aid in monitoring therapeutic response and predicting patient prognosis.

Conclusions:

• Specific clinical biomarkers are essential for improving the timeliness and accuracy of sepsis diagnosis.
• The judicious use of biomarkers can significantly enhance sepsis treatment strategies and patient outcomes.
• Continued research and validation of novel biomarkers are critical for advancing sepsis care.